WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)

[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3 WuXi PharmaTech Announces Second-Quarter 2014 Results Second-Quarter 2014 Highlights • Net Revenues Increased 14.8% Year Over Year to $163.4 Million]

By | 2016-03-24T03:28:54+00:00 August 14th, 2014|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3

[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3 WuXi PharmaTech Announces Second-Quarter 2014 Results Second-Quarter 2014 Highlights • Net Revenues Increased 14.8% Year Over Year to $163.4 Million]

By | 2016-03-24T03:30:17+00:00 August 14th, 2014|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13G: (Original Filing)

[Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 29,622,224 Item 6: 0 Item 7: 30,620,752 Item 8: 0 Item 9: 30,620,752 Item 11: 5.386% Item 12: FI Cusip #G98079109 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware]

By | 2016-03-24T03:49:54+00:00 June 10th, 2014|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More
Skip to toolbar